Background and Purpose-To date, there is no immediate radiographic surrogate to quantify primary cerebral injury to identify patients at risk for delayed cerebral ischemia and poor clinical outcome after aneurysmal subarachnoid hemorrhage. Therefore, we investigated the relation of early cerebral perfusion-computerized tomography and clot volume with radiological events of delayed cerebral ischemia and clinical outcome in patients with aneurysmal subarachnoid hemorrhage. Methods-Data from 2 cohorts of patients (51 in main, 28 patients in control cohort) with aneurysmal subarachnoid hemorrhage, receiving computerized tomography and perfusion-computerized tomography scanning <12 hours after ictus, were included. A risk group model for functional outcome was developed on the basis of early mean transit time (MTT) and volumetric blood clot measurements. The relation of the risk group model with subsequent MTT, angiographic vasospasm, new cerebral infarction, and functional outcome was analyzed. Actual and predicted functional outcomes based on the risk group model were compared in the control cohort. Results-The risk group model correlated significantly with subsequent MTT measurements, cerebral infarction, and functional outcome. Odds for poor outcome were significantly higher in case of concomitant increase of early MTT and clot volumes, as opposed to exclusive early MTT or clot volume increase. For patients in the high-or low-risk groups, neurological outcome in the control cohort correlated significantly with predicted outcomes. Conclusions-Assessment of early cerebral perfusion and intracranial blood clot may serve as a radiographic surrogate for delayed cerebral ischemia and functional outcome in patients with aneurysmal subarachnoid hemorrhage using risk group modeling. (Stroke. 2013;44:00-00.)
N eurological outcome of patients with aneurysmal subarachnoid hemorrhage (aSAH) is predominantly associated with the extent of primary cerebral injury and the incidence of delayed cerebral ischemia (DCI) as well as cerebral infarction. 1, 2 Ideally, the medical management of patients with aSAH would be adapted to a prognostic surrogate, related to the individual patient and the extent of primary cerebral injury. During the past decades, the main grading scales for assessment of primary cerebral injury and prediction of outcome in patients with aSAH were the clinical World Federation of Neurosurgical Societies (WFNS) grading scale and the radiological Fisher score, based on computerized tomography (CT). 3, 4 These historical grading scales, however, may be too insensitive as a surrogate for DCI and neurological outcome, especially because of interobserver variability and improved CT imaging quality. 5 Nevertheless, in clinical practice, an early radiological surrogate for primary cerebral injury to predict the subsequent extent of DCI and functional outcome has not yet been established. Data from animal and clinical studies strongly suggest that primary brain injury after aSAH is mainly reflected in early microvascular perfusion alterations, despite physiological cerebral perfusion or intracranial pressures. 6, 7 After experimental SAH, these microcirculatory alterations were reported to exacerbate with increasing amounts of subarachnoid blood clot. Assuming, then, that these alterations may be radiologically detected using early perfusion-CT scanning and intracranial blood clot measurements, we investigated a potential association with
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Methods

Patient Population
Out of a total of 153 patients admitted to our department between April 2010 and October 2011 because of aSAH, the present retrospective study analyzed data from a (main) cohort of 51 patients meeting the following selection criteria: (1) aSAH present on initial nonenhanced CT, applicable for volumetric measurements; (2) perfusion-CT (PCT) scanning time <12 hours after SAH ictus; and (3) no early angiographic vasospasm on admission demonstrated by digital subtraction angiography. Patients with unknown onset of SAH as well as patients with insufficient cerebral perfusion pressures (<65 mm Hg) attributable to intractable primary increase in intracranial pressures on admission were excluded from this analysis. A control cohort of 28 patients out of a total of 82 patients admitted to our department because of aSAH between November 2011 and September 2012, with identical selection criteria, was used to test the validity of the below described risk group model. In addition to consent from the patient or next of kin for data analysis, scientific use of the clinical data were approved by the local ethics committee of the Medical Faculty of the Heinrich-Heine University, Düsseldorf, Germany (study ID: 3573). The management of patients in the presented cohorts was in accordance with current SAH guidelines. 8 Patients with a Glasgow Coma Score <12 received an external ventricular drain for intracranial pressure control. In case of moderate-to-severe angiographic vasospasm, medical management consisted of induced hypertension and euvolemia. In case of refractory angiographic vasospasm, rescue therapy was initiated using endovascular intra-arterial infusion of nimodipine or balloon angioplasty (for severe proximal vasospasm refractory to intra-arterial nimodipine application).
SAH Screening Protocol and PCT Methods
All patients admitted to our department are subjected to a standardized PCT screening protocol. In addition to digital subtraction angiography on admission and on day 7 after SAH ictus, PCT measurements were routinely performed immediately on admission, 6 to 12 hours after aneurysm treatment, on days 3 to 4 as well as 9 to 11 after SAH ictus or in case of secondary neurological deterioration, that is, occurrence of clinical features of DCI. 9 PCT data were calculated using singular-value decomposition with an acquisition time of 35 seconds. The automated image analysis integrated a 1 cm cortical layer with 180 overlapping regions of interests and corresponding values, using 360° cortical banding analysis (Figure 1 ). After generation of perfusion maps, PCT data, such as mean transit time (MTT), time to peak of the residue function (T max ), cerebral blood flow, and cerebral blood volume were calculated using the STROKETOOL-CT software (Version 2.5, DigitalImageSolutions, Frechen, Germany). 10 Only MTT values were used for correlation with radiological events of DCI and poor outcome. The individual 180 (90 per hemisphere) MTT values of each PCT scan were pooled and expressed as mean values.
Definitions
Intracranial clot volume was calculated based on all pixels indicative for acute hemorrhage (60-90 Hounsfield units), on initial CT scan during admission. 11 Thus, the full subarachnoid clot as well as its intracerebral, intraventricular, or even subdural extension was included. Clot volume was measured using 3-dimensional volume rendering (OsiriX Version 3.7.1, Pixmeo SARL, Bernex, Switzerland) based on the initial CT scan on admission. Clot volumes for basal (2.5 mm slice thickness) and cranial slices (5 mm slice thickness) were added and expressed in mL. Early MTT was defined as MTT scanning time measured within 12 hours after aSAH ictus. Subsequent or followup MTT was defined as the pooled MTT data between day 1 and day 14 from each individual patient, excluding the early MTT measurements. Although absolute MTT threshold values may differ from previous studies, a 1.5-fold prolongation of reference MTT values from healthy patients was considered suggestive for DCI; this corresponded, according to our institutional hard-and software calibration, to an absolute MTT threshold of 4.2 seconds (normal range, 2.1-3.2 seconds). 12 Angiographic vasospasm was defined as narrowing of the arterial diameter of >30% from baseline. New cerebral infarction was diagnosed and defined as the presence of cerebral infarction on CT scan within 6 weeks after SAH, or on the latest CT made before death within 6 weeks and resulting from DCI when not attributable to other causes, such as aneurysm treatment or intraparenchymal hematoma. 9 Functional outcome, as measured by Glasgow Outcome Score (GOS), was assessed at discharge and after 6 weeks and dichotomized in poor (GOS, 1-3) and good neurological outcomes (GOS, 4-5). Assessment of radiographic and neurological outcome measures was performed by investigators (N.E., H.H.) blinded to clot volume and CT perfusion measurements.
Statistical Analysis
A logistic regression model with stepwise backward exclusion of the following variables was used to determine their influence on dichotomized functional outcome: patient age, sex, initial WFNS grade, Fisher score, early MTT, and clot volume. Predictive values of early MTT and clot volume for functional outcome were analyzed using receiver-operator characteristics analysis. The area under the curve was calculated to determine the cutoff values based on highest sensitivity and specificity for outcome prediction. Based on these cutoff values for early MTT and clot volume, patients were categorized into 3 different risk groups: (1) low risk with low-early MTT values and low-clot volumes (2) intermediate risk with low-early MTT and highclot volumes or high-early MTT values and low-clot volumes, and (3) high risk with high-early MTT and high-clot volumes. The correlation of this risk group allocation with subsequent MTT values, incidence of angiographic vasospasm, and new cerebral infarction, as well as functional outcome at discharge and at 6 weeks, were calculated. Odds ratios, likelihood ratios, sensitivity, and specificity for new cerebral infarction, and poor outcome after 6 weeks (poor GOS) were calculated for the different risk groups. Additionally, the initial WFNS and Fisher grading scores were correlated with incidence of cerebral infarction and functional outcome at 6 weeks. Finally, outcome prediction was tested in the control cohort using the below described risk group model derived from the main cohort, by correlating actual clinical outcomes and projected outcomes, based on early MTT and clot volume risk group allocation. To evaluate the quality of the risk group model, a logistic regression analysis with the patient data from the control cohort was done. Spearman correlation for ordinal variables and Pearson product-moment correlation were used for metric or continuous variables. According to scale levels either Student t test or nonparametric tests were used to determine differences between groups. Significance was accepted at a level of P≤0.05. All statistic analysis was performed using SPSS 15.0.1 (Ulead Technologies, Chicago, IL).
Results
All 51 patients received CT and PCT scanning <12 hours (mean 6±3.5 hours) after SAH ictus as well as before treatment of the ruptured aneurysm. Mean patient age was 54.8 ± 12.0 years (mean±SD), and mean intracranial clot volume was 48.3±44.8 mL in the cohort (Table 1 ). In addition to the initial WFNS grade, the logistic regression model identified both intracranial clot volume and early MTT as significant and independent contributors to predict dichotomized outcome (Nagelkerke R²=0.842). The receiver-operator characteristics curves designed to determine the cutoff values for early MTT and clot volume with the highest sensitivity/specificity analysis for functional outcome prediction were used to define the following risk groups: (1) low risk with early MTT <4.2 seconds and clot volume <50 mL (n=27), (2) 
Risk Group Analyses
There was a strong correlation of risk group allocation, derived from early PCT and clot volume measurements, with radiographic and neurological outcome events, as compared with the WFNS and Fisher grading scores in the cohort (Figure 2) . Furthermore, there was a significant difference in neurological outcome, as measured by GOS after 6 weeks, between the 3 risk groups (Figure 3) . Additionally, patients within the highrisk group demonstrated significantly greater odds to have cerebral infarctions and poor outcome at 6 weeks (Table 2) . Interestingly, there was no difference in the incidence of angiographic vasospasm between the risk groups (P=0.733). 
As illustrated in the
Discussion
The main findings of this retrospective analysis in patients with aSAH are the following: (1) the risk group model correlated significantly with subsequent MTT measurements, cerebral infarction, and functional outcome, (2) odds for poor outcome were significantly higher in case of concomitant increase of early MTT and clot volumes, as opposed to exclusive early 
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MTT or clot volume increase, and (3) for patients in the highor low-risk groups, neurological outcome in the control cohort correlated significantly with predicted outcomes. Perfusion CT during the course of aSAH is increasingly thought to provide a more comprehensive insight on pathological macrocirculatory and microcirculatory alterations, as opposed to sole angiographic assessment of cerebral arteries. [13] [14] [15] Nevertheless, the role of early cerebral perfusion imaging for prediction of the subsequent extent of secondary cerebral injury, thus neurological outcome after SAH remains unclear. In general, previous studies within this context partially support our findings but (1) used heterogeneous definition of early PCT scanning, 12-72 hours after SAH ictus, (2) solely investigated poor grade SAH patients, WFNS IV and V, (3) reported on data derived from smaller patient cohorts and, importantly, (4) did not include clot volume measurements in early radiographic risk prediction. 7, [16] [17] [18] [19] It is known that (1) 10% to 20% of patients may present with early angiographic vasospasm during 24 hours after SAH ictus and (2) poor grade SAH is strongly associated with poor outcome, per se. 2, 20 However, such studies should particularly address the early and more sensitive identification of those patients with SAH, with initial good clinical grades, who are at increased risk for subsequent DCI and poor outcome. Nevertheless, the largest study on 75 patients, with PCT scanning within 72 hours after SAH ictus, reported an association with the subsequent incidence of DCI but not with cerebral infarction or neurological outcome. 18 Despite the prolonged PCT imaging time-span of up to 72 hours, these data partially underscore our findings, as exclusive early MTT prolongation or high-clot volumes (intermediate risk group) seemed to have less severe impact on outcome. Thus, our study is the first to describe the additive impact of concomitant early PCT alterations and intracranial clot volumes on radiological events of DCI and poor neurological outcome during the course of SAH based on risk group allocation.
There are different explanations for our results. Most likely, patients with early MTT prolongation and increased clot volumes (high risk group) in the absence of large vessel spasm have early microcirculatory disturbances, which additively results in an increased predisposition to secondary ischemic damage and poor functional outcome during the course of SAH. Early and delayed microcirculatory dysfunction after experimental or aneurysmal SAH is increasingly thought to be associated with the incidence of DCI, in the absence of macrovascular spasm or changes in cerebral perfusion pressure. 6, 21 One possible pathomechanism for this phenomenon might be endothelin-1-mediated vasoconstriction of microvessels. 22 Alternatively, endothelial dysfunction may also impose an increased vulnerability for DCI in patients early after SAH. 22, 23 Furthermore, the increased incidence of DCI after concomitant early perfusion impairment and increased subarachnoid blood clot (high-risk group) in our study may reflect an exacerbation of SAH-related endothelial dysfunction. 24 Finally, our results reflect recent studies on the dissociation of angiographic vasospasm and poor neurological outcome and support the assumption that cerebral infarction might reflect the ultimate end point of different, proischemic pathomechanisms (eg, microthromboembolism, microvascular spasm, cortical spreading ischemia, impaired autoregulation). 2, 25, 26 We acknowledge several limitations of our study. First, CT perfusion screening may only be applied in patients with normal renal function. In the present study, 3 out of the 153 patients in the main cohort, as well as 1 out of 82 patients in the control cohort, were not included to standard PCT imaging because of renal insufficiency. Furthermore, aside from the radiation exposure, ideally, diffusion-weighted MRI would be more sensitive than CT scanning for detection of ischemic lesions after aSAH. 27 However, aside from its impractical use for intensive care unit patients, the nonlinear relation of contrast-agent concentration and signal intensity in MR diffusion/perfusion may result in intraindividual and interindividual data bias, thus not permitting the establishment of MRI screening protocols or thresholds. Second, because of its high sensitivity/specificity, we solely focused on MTT as the main PCT parameter in our analysis. Nevertheless, the presented absolute MTT cutoff values may differ from other studies and might not be directly attributable to other PCT scanners or algorithms. Considering cutoff values at 1.5-fold prolongation of reference MTT, our results are well in line with those from other studies. 12 Third, we excluded patients with early macrovascular spasm and primary intractable increase of intracranial pressure, thus eliminating patients with primary insufficient cerebral perfusion pressure from our analysis. However, as in previous studies, we defined our selection criteria to further elucidate the sequence of primary brain injury, early microcirculatory alterations, DCI, and functional outcome. 7, 21, 28 Fourth, our softwarebased calculation of intracranial blood volumes did not permit further differentiation or subanalysis of subarachnoid, intraventricular or intraparenchymal blood clot components.
However, the benefit from Hounsfield-unit-derived blood clot definition as opposed to manual inclusion and exclusion of different blood clot components is less interobserver bias. Ultimately, the role of risk prediction in patients with exclusive increase of early MTT or blood clot remains to be elucidated.
In summary, risk group allocation, derived from early MTT and intracranial blood clot measurements correlated significantly with subsequent MTT measurements, incidence of new cerebral infarction, and poor functional outcome. Our data suggest that acute PCT disturbances may reflect early microcirculatory impairment, which is significantly amplified with concomitant increase in clot volumes, predisposing patients for subsequent ischemic damage. Therefore, early MTT and intracranial blood clot might serve for assessment of primary Table 1 Control cohort (n=28 patients) for validation of the risk group model, with relevant epidemiological and clinical data. Patients were classified into risk groups according to the established criteria from the previous 51 patients in the main cohort. After risk group allocation a dichotomized outcome (good vs. poor) was predicted (projected GOS group). Actual outcome after 6 weeks was then recorded (GOS group). Outcome prediction was correct in 90% of the cases (18/20) . However, as clinical outcome in patients classified into the intermediate risk group (n=8) was not significantly associated with either good or poor functional outcome according to the risk group model, outcome for these patients was defined as "unknown". Two patients with incorrect outcome prediction are marked in bold.
